The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology’s Divergent Thinkers

Rheumatology’s Divergent Thinkers

February 1, 2008 • By Gretchen Henkel

  • Tweet
  • Email
Print-Friendly Version / Save PDF

If rheumatology organizations could be assigned human characteristics, OMERACT (which stands for Outcome Measures in Rheumatology, formerly Outcome Measures in Rheumatology Clinical Trials) would be the family’s divergent thinker. It has now been 16 years since the first international conference to achieve consensus about outcomes measures in rheumatology took place. Every two years since 1992, OMERACT has been providing an intellectual forum where an international community of clinicians, scientists, and regulatory, industry, and patient representatives sits down as equals to hammer out agreement on common endpoints to be used in clinical trials in the rheumatic diseases.

You Might Also Like
  • Omeract How to Get into the “Act”
  • Patients Add Power to Research Initiatives
  • Thinkers Wanted: Join the Grassroots Rheumatology Think Tank
Explore This Issue
February 2008
Also By This Author
  • Rheumatologist Deborah Desir Brings Advocacy, Fundraising to the Home Front

Like nurturing parents, OMERACT’s five executive committee members are justifiably proud, and even a bit amazed, at the way in which OMERACT’s unique organizational structure continues to build on its initial mission. Peter Brooks, MD, executive dean of health sciences at the University of Queensland in Brisbane, Australia, one of the original OMERACT founders and a current executive committee member, says, “Most organizations have to reinvent themselves after about a decade. But OMERACT doesn’t seem to have had to do that. It’s been 16 years and we’re still going strong and still expanding.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Lee S. Simon, MD, associate clinical professor of medicine at Harvard Medical School in Boston and another executive committee member, says, “I’m involved in many other groups, and this has been the largest effort to be open of any group I’ve ever seen.”

TR talked recently with several of the founders and members of OMERACT to solicit their reflections on the organization’s purpose, accomplishments, and future opportunities and challenges.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
OMERACT Executive Committee members and spouses at a dinner held during the Malta conference. Clockwise from left: Rob Kew, OMERACT conference organizer; Mrs. Boers; Dr. Boers; Dr. Tugwell; Leanne Idzerda, OMERACT secretary; Dr. Brooks; Mrs. Tugwell; Dr. Simon; Jack Loftis, PhD; Dr. Strand.
OMERACT Executive Committee members and spouses at a dinner held during the Malta conference. Clockwise from left: Rob Kew, OMERACT conference organizer; Mrs. Boers; Dr. Boers; Dr. Tugwell; Leanne Idzerda, OMERACT secretary; Dr. Brooks; Mrs. Tugwell; Dr. Simon; Jack Loftis, PhD; Dr. Strand.

Why the Need?

For a specialty in which international collaborations and a focus on outcomes seem relatively common today, why would an initiative such as OMERACT be needed? In 1990, it was a different story. At that time, outcomes measurement was a huge challenge in clinical trials, says Vibeke Strand, MD, clinical professor of medicine in the division of immunology at Stanford University in Palo Alto, Calif., and another OMERACT executive committee member. Researchers in North America used different trial endpoints from their colleagues in Europe and regulatory agencies did not accept results of trials from countries other than their own.

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Meeting Reports, Practice Management Tagged With: clinical trials, International, measures, OMERACT, Outcome Measures in Rheumatology, OutcomesIssue: February 2008

You Might Also Like:
  • Omeract How to Get into the “Act”
  • Patients Add Power to Research Initiatives
  • Thinkers Wanted: Join the Grassroots Rheumatology Think Tank
  • Large Vessel Vasculitis Outcome Measures: An Update from OMERACT

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)